Federal Register
Notices > Notice of Registration
2006 >
Cerilliant API Services LLC
FR Doc E6-12478 [Federal Register: August 2, 2006 (Volume 71, Number 148)]
[Notices] [Page 43813] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02au06-110]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated March 20, 2006 and published in the Federal Register on March
24, 2006, (71 FR 14948), Cerilliant API Services LLC, 811 Paloma Drive, Suite A,
Round Rock, Texas 78664, made application to the Drug Enforcement Administration
(DEA) to be registered as a bulk manufacturer of the basic classes of controlled
substances listed in Schedule I and II; and by letter to modify its name to
Austin Pharma LLC. Subsequent to the publication of the Notice of Application,
by letter, the company has also requested to withdraw thirty-five drug codes
from their initial application request.
Drug
|
Schedule
|
Marihuana (7360)
|
I
|
Tetrahydrocannabinols (7370)
|
I
|
Alphamethadol (9605)
|
I
|
Methadone (9250)
|
II
|
Methadone intermediate (9254)
|
II
|
Levo-alphacetylmethadol (9648)
|
II
|
Alfentanil (9737)
|
II
|
Remifentanil (9739)
|
II
|
Sufentanil (9740)
|
II
|
Fentanyl (9801)
|
II
|
The company plans to manufacture the listed controlled substances in bulk for
distribution to its customers.
In reference to drug code 7360 (Marihuana), the company plans to bulk
manufacture cannabidiol as a synthetic intermediate. This controlled substance
will be further synthesized to bulk manufacture a synthetic THC (7370). No other
activity for this drug code is authorized for this registration.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Cerilliant API
Services LLC to manufacture the listed basic classes of controlled substances is
consistent with the public interest at this time. DEA has investigated
Cerilliant API Services LLC to ensure that the company's registration is
consistent with the public interest. The investigation has included inspection
and testing of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21
U.S.C. 823, and in accordance
with 21 CFR
1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-12478 Filed 8-1-06; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|